Abstract
Vaccination has become a paradigm of preventative medicine, as it is both efficacious and cost-effective. The ability of vaccines to elicit specific immune responses is the key to their efficacy. There are two methods by which vaccines elicit immune responses. The first vaccines developed consisted of live attenuated pathogens which infect the host and stimulate a protective immune response. This includes the smallpox vaccine and the Sabin polio vaccine. The second method of vaccination was the development of killed pathogens or subunits. This includes the Salk polio vaccine (killed polio virus) and the hepatitis vaccine (recombinant surface antigen glycoprotein). These killed and subunit preparations have been also of great utility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nabel EG, Plautz G, Nabel GJ (1990) Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249: 1285–1288
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1468
Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352: 815–818
Israel MA, Chan TW, Hourihan SL, Rowe WP, Martin MA (1979) Biological activity of polyma viral DNA in mice and hamsters. J Virol 29: 990–996
Tang DC, De Vit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152–154
Fynan EF, Robinson HL, Webster RG (1993) Use of DNA encoding influenza hemag-glutin and avian influenza vaccine DNA. DNA and Cell Biology 12: 785–789
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, De Witt CM, Friedman A et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749
Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato Al, Boyer J, Williams WV, Weiner DB (1993) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90: 4156–4160
Cheng L, Ziegelhoffer PR, Yang NS (1993) In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 90: 4455–4459
Carson DA, Raz E (1997) Oligonucleotide adjuvants for T helper I (Th 1)-specific vaccination. J Exp Med 186: 1621–1622
Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93: 2879–2883
Krieg AM, Yi AK. Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546–549
Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E (1996) immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352–354
Yi AK, Chace JH, Cowdery JS, Krieg AM (1996) IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol 156: 558–564
Xiang Z, Ertl HC (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2: 129–135
Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB (1997) In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. J Immunol 158: 816–8
Kim JJ, Bagarazzi ML, Trivedi N, Hu Y, Kazahaya K, Wilson DM, Ciccarelli R, Chattergoon MA, Dang K, Mahalingarn S, Chalian AA, Agadjanyan MG, Boyer JD, Wang B, Weiner DB (1997) Engineering of in vivo immune responses to DNA immunization via co-delivery of co-stimulator molecule genes. Nat Biotechnol 15: 641–646
Bueler H, Mulligan RC (1996) Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by co-expression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol Med 2: 545–555
Coney L, Wang B, Ugen KE, Boyer J, McCallus D, Srikantan V, Agadjanyan M, Pachuk CJ, Herold K, Merva M et al (1994) Facilitated DNA inoculation induces anti-HIV-I immunity in vivo. Vaccine 12: 1545–1550
Johnston SA, Tang DC (1993) The use of microparticle injection to introduce genes into animal cells in vitro and in vivo. Genet Eng 15: 225–236
Johnston SA, Tang DC (1994) Gene gun transfection of animal cells and genetic immunization. Methods Cell Biol 43: 353–365
Flynn EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90: 11478–11482
Livingston JB, Lu S, Robinson HL, Anderson DJ (1995) The induction of mucosal immunity in the female genital tract using gene-gun technology. Part 1: Antigen expression. Ann NY Acad Sci 772: 265–357
Wang B, Dang K, Agadjanyan MG, Srikantan V, Li F, Ugen KE, Boyer J, Merva M, Williams WV, Weiner DB (1997) Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine 15: 821–825
Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K (1997) Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 159: 3638–3647
Corr M, Lee DJ, Carson DA, Tighe H (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J tExp Med 184: 1555–1560
Fu TM, Ulmer JB, Caulfield MJ, Deck RR, Friedman A, Wang S, Liu X, Donnelly JJ, Liu MA (1997) Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 3: 362–371
Iwaski A, Torres CA, Ohashi PS, Robinson HL, Barber BH (1991) The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 159: 11–14
Doe B, Selby M, Barnett S, Baenziger J, Walker CM (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 93: 8578–8583
Martinez X, Brandt C, Saddallah F, Tougne C, Barrios C, Wild F, Dougan G, Lambert PH, Siegrist CA (1997) DNA immunization circumvents deficient induction of T helper type I and cytotoxic T lymphocyte responses in neonates and during early life. Proc Natl Acad Sci USA 94: 8726–8731
Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M, Swain SL, Spiegelberg HL, Carson DA (1996) Preferential induction of a Thl immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 93: 5141–5145
Inchauspe G, Vitvitski L, Major ME, Jung G, Spengler U, Maisonnas M, Trepo C (1997) Plasinid DNA expressing a secreted or a non-secreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA and Cell Biology 16: 185–195
Barry MA, Johnston SA (1997) Biological features of genetic immunization. Vaccine 15: 788–791
Feltquate DM, Heaney S, Webster RG, Robinson HL (1997) Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158: 2278–2284
Pertmer TM, Roberts TR, Haynes JR (1996) Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 70: 6119–6125
Leclerc C, Deroaid E, Rojas M, Whalen RG (1997) The preferential induction of a Th 1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid. DNA and Cell Immunology 179: 97–106
Halpern MD, Kurlander RJ, Pisetsky DS (1996) Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell Immunol 1: 72–78
Maecker HT, Umetsu DT, DeKruyff RH, Levy S (1997) DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin Vaccine 15: 1687–1696
Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158: 4591–4601
Klenerman P, Hengartner H, Zinkernagel RM (1997) A non-retroviral RNA virus persists in DNA form. Nature 390: 298–301
Lee DJ, Tighe H, Corr M, Roman M, Carson DA, Spiegelberg HL, Raz E (1997) Inhibition of IgE antibody formation by plasmid DNA immunization is mediated by both CD4+ and CD8+ T cells Int. Arch Allergy Immunol 113: 227–230
Hsu CH, Chua KY, Tao MH, Lai YL, Wu HD, Huang SK, Hsieh KH (1996) Immuno-prophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperrespon-siveness in vivo by genetic immunization. Nat Med 2: 540–544
Hsu CH, Chua KY, Tao MH, Huang SK, Hsieh KH (1996) Inhibition of specific IgE response in vivo by allergen-gene transfer. Int Immunol 8: 1405–1411
Ragno S, Colston MJ, Lowrie DB, Winrow VR, Blake DR, Tascon R (1997) Protection of rats from adjuvant arthritis by immunization with naked DNA encoding for mycobacterial heat shock protein 65. Arthritis Rheum 40: 277–283
Raz E. DudlerJ, Lotz M, Baird SM, Berry CC, Eisenberg RA, Carson DA (1995) Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4: 286–292
Ghosh SK, Wong J, Banked RB (1987) Idiotype-specific T lymphocytes responsible for the selection 6T somatic variants of a B cell hybrid. J Immunol 145: 365–370
Ghosh SK, White LM, Ghosh R, Bankert RB (1990) Vaccination with membrane associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype. J Immunol 145: 365–370
Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R (1990) Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor Immunity. J Immunol 145: 1029–1036
Tao M-H, Levy R (1993) Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362: 755–758
Conry RM, Lo Buglio AF, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, Curiel DT (1994) Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res 54: 1164–1168
Conry RM, Lo Buglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Curiel DT (1995) A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther 2: 59–65
Wang B, Merva M, Dang K, Ugen KE, Williams WV, Weiner DB (1995) Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Hum Gene Ther 6: 407–418
Irvine KR, Rao JB, Rosenberg SA, Restifo NP (1996) Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 156: 238–245
Ciernik T, Berzofsky JA, Carbone DP (1996) Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J Immunol 156: 2369–2375
Syrengelas AD, Chen TT, Levy R (1996) DNA immunization induces protective immunity against B-cell lymphoma. Nat Med 2: 1038–1041
Spellerberg MB, Zhu D, Thompsett A, King CA, Hamblin TJ, Stevenson FK (1997) DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain FV genes by fusion to tetanus toxin fragment C. J Immunol 159: 1885–1892
Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JR, Brocke S, Mor F, Cohen IR, Steinman L (1996) Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoirnmime encephalomyelitis and activates Th2 immunity. Nat Med 2: 899–905
Desquenne-Clark L, Esch TR, Otvos L, Heber-Katz E (1991) T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 88: 7219–7223
Howell M, Winters S, Olee T, Powell H, Carlo D, Brostoff S (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.. Science 246: 668–670
Vlahakos DV. Foster MH, Adams S, Katz M, Uccl AA, Barrett KJ, Datta SK, Madaio MP (1992) Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 41: 1690–1700
Boyer JD, Wang B, Ugen K-E, Agadjanyan M, Javadian A, Frost P, Dang K, Carrano RA, Ciccarelli R, Coney L, Williams WV, Weiner DB (1996) In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 25: 242–250
Biocca S, Neuberger MS, Cattaneo A (1990) Expresssion and targeting of intracellular antibodies in mammalian cells. EMBO J 9: 101–108
Srikantan V, Wang B, Satre MA, Ugen KE, Dang K, Scales F, Godillot AP, Williams WV, Weiner DB (1994) Cloning and biological characterization of human single-chain Fv fragments that mediate neutralization of HIV-1. Aids 8: 1525–1532
Nilsson T, Jackson M, Peterson PA (1989) Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58: 707–719
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Godillot, A.P., Madaio, M., Weiner, D.B., Williams, W.V. (2000). DNA vaccination as an anti-inflammatory strategy. In: Evans, C.H., Robbins, P.D. (eds) Gene Therapy in Inflammatory Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8478-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8478-5_11
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9584-2
Online ISBN: 978-3-0348-8478-5
eBook Packages: Springer Book Archive